CMS Belgium, alongside CMS France, CMS Netherlands, Torys LLP and FAS Advogados in cooperation with CMS, advised Pricoa Private Capital, leading US institutional investor, in connection with the new USPP bond issue under Belgian law of Biobest Group (now BioFirst Group), a world leader in pollination and integrated biological control.
The USD45 million, 10-year private placement was executed using USPP documentation in line with standard US market practice but is governed by Belgian law.
The purpose of this transaction is to finance the balance of the price owed by Biobest (BioFirst) for the acquisition of Biotrop Participações S.A. in Brazil.
The teams advising Pricoa Private Capital on this transaction from CMS (France, Belgium and the Netherlands), Torys LLP (Canada) and FAS Advogados (CMS' partner in Brazil) consisted of:
- CMS Belgium: Benoît Vandervelde (Partner), Anaïs Casteur (Associate), for capital markets aspects, and Arnout Vaninbroukx (Counsel), for tax aspects
- CMS France: Marc-Etienne Sébire (Partner), Myriam Issad and Pierre Maunand (Associates), for capital markets aspects
- CMS Netherlands: Etiënne Courbois (Partner), Mathijs van der Veen and Camiel de Zoeten (Associates)
- Torys LLP: Tom Zverina (Partner) and Jacob Weinstock (Associate)
- FAS Advogados: Vicente Piccoli M. Braga (Partner), Karine Oliveira and Ana Thereza M. Aguiar Vilela (Associates)
